ANALYSIS OF THE DEVELOPMENT OF MYCOTIC INFECTIONS IN PATIENTS USING CANAGLIFLOZIN AND DAPAGLIFLOZIN: A NARRATIVE REVIEW (Atena Editora)

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributor.authorAMORIM, VINICYUS EDUARDO MELO-
Autor(es): dc.contributor.authorMOURA, HELOISE GABRIELLA QUEIROZ-
Autor(es): dc.contributor.authorGOMES, CAMILLA MARIA GALVÃO-
Autor(es): dc.contributor.authorCUNHA, EMILLEY ANDRADE-
Autor(es): dc.contributor.authorCUNHA, KETHLY DE ANDRADE-
Autor(es): dc.contributor.authorMELO, FELIPE OLIVEIRA MIRANDA DE-
Autor(es): dc.contributor.authorMEDEIROS, MARIA EDUARDA NUNES DE FIGUEIREDO-
Autor(es): dc.contributor.authorMELO, ENDERSON LIMA PEDROSA DE-
Autor(es): dc.contributor.authorMAIA, RENATA CORREIA CARVALHO NOVAES FERRAZ-
Autor(es): dc.contributor.authorSILVA, FELIPE SANTOS DA-
Autor(es): dc.contributor.authorFREIRE, MARIANA CANTARELLI-
Data de aceite: dc.date.accessioned2023-04-17T13:02:25Z-
Data de disponibilização: dc.date.available2023-04-17T13:02:25Z-
Data de envio: dc.date.issued2023-03-30-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/725617-
Resumo: dc.description.abstractSGLT-2 inhibitors are very useful and effective medications for treating hyperglycemia and reducing cardiovascular risk. However, it is responsible for increasing the IGM index, especially in women, three to four times when compared to a placebo group. As such, it is imperative that healthcare professionals are aware of the benefits, risks, and strategies for increasing safety and efficacy, and managing SGLT2 inhibitor-related issues. The incidence, risk factors, prevention and management of IGMs associated with SGLT2 inhibitors must be discussed as part of shared decision-making models. Furthermore, risk mitigation must include optimizing glycemic, metabolic, and cardiovascular management strategies, as well as providing personal hygiene advice, avoiding unnecessary discontinuation of therapy with SGLT2 inhibitors.pt_BR
Idioma: dc.language.isoenpt_BR
Palavras-chave: dc.subjectDapagliflozinpt_BR
Título: dc.titleANALYSIS OF THE DEVELOPMENT OF MYCOTIC INFECTIONS IN PATIENTS USING CANAGLIFLOZIN AND DAPAGLIFLOZIN: A NARRATIVE REVIEW (Atena Editora)pt_BR
Tipo de arquivo: dc.typelivro digitalpt_BR
Aparece nas coleções:Livros digitais